Innovate UK, as part of UK Research and Innovation, will invest up to £25 million in the best game-changing or disruptive ideas with a view to commercialisation
£25,000 – £500,000 (6 –18 months)
£25,000 – £2,000,000 (19 –36 months)
Your proposal must demonstrate a clear game-changing and/or disruptive innovative idea leading to new products, processes or services.
Projects should be business focused, rather than pure research.
Applications can come from any area of technology (including arts, design, media or creative industries), science or engineering and be applied to any part of the economy.
Proposals must demonstrate an idea that is significantly ahead of others in the field, set for rapid commercialisation.
More information about eligibility here
This competition encourages investment in innovative immersive technology companies. The investment accelerator will fund innovative high-risk projects and invest in companies that have potential for growth.
Despite the growth of the immersive technology market, the finance and investment ‘ecosystem’ is undeveloped, particularly for early stage companies that need seed funding to support R&D and grow.
This competition has been designed to encourage early-stage private investment in innovative immersive content, products, platforms, services, software and hardware, to give companies greater confidence that investment will continue after the project funding.
Projects should focus on one or more of the following:
• enhancing, extending or transforming the immersive audience experience
• new immersive content production tools, software and systems
• VR, AR and other digital technologies to deepen and enrich the immersive experience
£150 – 300k
You can find out more here
The aim is to improve front-line clinical decision making and patient management in unscheduled care facilities.
The overall programme will be delivered in 2 phases. A decision to proceed with phase 2 will depend on the outcomes from phase 1. Phase 1 research and development contracts will be focused on feasibility studies. Phase 2 contracts will be prototype development and testing.
The challenge is to develop an AI or machine-based learning programme that can help healthcare organisations accurately identify whether a patient has a fracture.
This is initially a classification problem (by assigning a value of yes, no or maybe). This is an initial step towards integrating AI systems into a mainstream clinical workflow within the NHS and could be a platform for building more intelligent learning systems.
£20k (phase 1)
More information can be found here